Active, Not Recruiting
A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
Led by TLC Biopharmaceuticals, Inc. · Updated on 2026-07-02
304
Participants Needed
4
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
This is a Phase 3, randomized, double-blind, comparator- and placebo-controlled study to evaluate analgesic efficacy and safety of TLC590 via local infiltration in adult subjects following bunionectomy.
CONDITIONS
Brief Title
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here